Global Next Generation Sequencing Ngs Market
Tamaño del mercado en miles de millones de dólares
Tasa de crecimiento anual compuesta (CAGR) :
% 
USD
15.98 Billion
USD
49.21 Billion
2024
2032
 Período de pronóstico |
2025 –2032 |
 Tamaño del mercado (año base) |
USD 15.98 Billion |
 Tamaño del mercado (año de pronóstico) |
USD 49.21 Billion |
 Tasa de crecimiento anual compuesta (CAGR) |
% |
| Jugadoras de los principales mercados |
Mercado global de secuenciación de próxima generación (NGS), por producto y servicio (consumibles, servicios e instrumentos), tecnología (secuenciación por síntesis (SBS), secuenciación por ligadura (SBL) y otros), aplicación (microbiología farmacéutica, descubrimiento de fármacos y biomarcadores, diagnóstico, medicina de precisión, investigación agrícola y animal, detección de patógenos alimentarios y otros), usuario final (empresas farmacéuticas y de biotecnología, institutos académicos y de investigación, hospitales y clínicas, laboratorios clínicos, organizaciones de investigación por contrato (CROS) y otros), canal de distribución (licitación directa, ventas minoristas y otros) - Tendencias de la industria y pronóstico hasta 2031.
Análisis y tamaño del mercado de secuenciación de próxima generación (NGS)
El mercado mundial de secuenciación de próxima generación (NGS) está impulsado por la creciente demanda de medicina personalizada y la creciente adopción de tecnologías NGS en diagnósticos clínicos y aplicaciones de investigación. Sin embargo, una limitación para el crecimiento del mercado es el alto costo asociado con los procedimientos NGS, lo que limita su accesibilidad en las regiones en desarrollo. Una oportunidad en este mercado radica en los avances en las tecnologías NGS, como herramientas de análisis de datos mejoradas y plataformas de secuenciación más rápidas, que pueden mejorar la eficiencia y la precisión de los procesos de secuenciación. Un desafío es la necesidad de protocolos y regulaciones estandarizados para las pruebas basadas en NGS para garantizar la coherencia y la confiabilidad en diferentes laboratorios y entornos de atención médica.
Data Bridge Market Research analiza que el mercado global de secuenciación de próxima generación (NGS) está creciendo con una CAGR del 15,1% en el período de pronóstico de 2024 a 2031 y se espera que alcance los USD 40,78 mil millones para 2031 desde USD 13,88 mil millones en 2023.
|
Métrica del informe |
Detalles |
|
Período de pronóstico |
2024 a 2031 |
|
Año base |
2023 |
|
Años históricos |
2022 (Personalizable 2016-2021) |
|
Unidades cuantitativas |
Ingresos en miles de millones de USD |
|
Segmentos cubiertos |
Producto y servicio (consumibles, servicios e instrumentos), tecnología (secuenciación por síntesis [SBS], secuenciación por ligación [SBL] y otros), aplicación (microbiología farmacéutica, descubrimiento de fármacos y biomarcadores, diagnóstico, medicina de precisión , investigación agrícola y animal, detección de patógenos alimentarios y otros), usuario final (empresas farmacéuticas y de biotecnología, institutos académicos y de investigación, hospitales y clínicas, laboratorios clínicos, organizaciones de investigación por contrato [CROS] y otros), canal de distribución (licitación directa, ventas minoristas y otros) |
|
Países cubiertos |
EE. UU., Canadá y México, Reino Unido, Alemania, Francia, España, Italia, Bélgica, Rusia, Suiza, Países Bajos, Turquía, resto de Europa, China, Australia, Japón, India, Singapur, Corea del Sur, Malasia, Tailandia, Indonesia, Filipinas, resto de Asia-Pacífico, Brasil, Argentina y resto de Sudamérica, Sudáfrica, Egipto, Arabia Saudita, Emiratos Árabes Unidos, Israel y resto de Oriente Medio y África. |
|
Actores del mercado cubiertos |
Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Charles River Laboratories, Revvity, Promega Corporation, Agilent Technologies, Inc., Takara Bio Inc., Eurofins Scientific, Hamilton Company, BGI, Azenta US, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., PacBio., Macrogen, Inc., Gilson Incorporated, New England Biolabs, Oxford Nanopore Technologies plc., LGC Biosearch Technologies, PCR Biosystems, ACT Genomics, Quantabio, DNASTAR y NimaGen, entre otros. |
Definición de mercado
La secuenciación de nueva generación (NGS), también conocida como secuenciación de alto rendimiento, es una potente tecnología que se utiliza para secuenciar rápidamente ADN y ARN. A diferencia de la secuenciación Sanger tradicional, que es más lenta y más cara, la NGS permite la secuenciación simultánea de millones de fragmentos de ADN, lo que permite a los investigadores analizar de forma rápida y eficiente genomas grandes, identificar variaciones genéticas y estudiar patrones de expresión génica. La NGS ha revolucionado la investigación genómica, al permitir nuevas visiones sobre la base genética de las enfermedades, la diversidad de las comunidades microbianas y la evolución de las especies.
Dinámica del mercado global de secuenciación de próxima generación (NGS)
En esta sección se aborda la comprensión de los factores impulsores, las ventajas, las oportunidades, las limitaciones y los desafíos del mercado. Todo esto se analiza en detalle a continuación:
Conductores
- Aumento de la adopción de la farmacología centrada en el genoma
La creciente adopción de la farmacología genómica está actuando como un importante impulsor del mercado global de secuenciación de próxima generación (NGS), transformando el panorama de la medicina personalizada y las terapias dirigidas. A medida que los proveedores de atención médica reconocen el valor de adaptar los tratamientos en función de los perfiles genéticos individuales, ha aumentado la demanda de secuenciación genómica precisa y de alto rendimiento. Las tecnologías NGS permiten un análisis integral del genoma de un paciente, lo que permite la identificación precisa de las variantes genéticas que influyen en la respuesta a los medicamentos, la resistencia y los posibles efectos adversos. Este nivel de conocimiento personalizado guía a los médicos en la selección de los tratamientos más eficaces y seguros para cada paciente, mejorando los resultados y reduciendo la prescripción por ensayo y error. Como resultado, el mercado de NGS se está expandiendo rápidamente, impulsado por la creciente adopción de la farmacología genómica en varios campos médicos y su potencial para revolucionar la atención y los resultados de los pacientes.
- Amplia cartera de productos ofrecida por los principales actores
Una amplia cartera de productos ofrecida por los actores del mercado es un factor clave para el crecimiento del mercado global de secuenciación de próxima generación (NGS), ya que brinda a los clientes una amplia variedad de soluciones para satisfacer diversas necesidades clínicas y de investigación. Al ofrecer una variedad de plataformas, consumibles y software de NGS, los actores del mercado pueden atender diferentes niveles de complejidad de investigación, requisitos de rendimiento y limitaciones presupuestarias. Esta versatilidad permite a los investigadores y médicos seleccionar las herramientas más apropiadas para sus aplicaciones específicas, ya sea secuenciación de genoma completo, secuenciación dirigida o análisis de transcriptomas. Además, una amplia cartera puede incluir ofertas especializadas como kits para genómica del cáncer, estudios de microbioma e investigación de enfermedades raras, lo que atrae aún más a una amplia gama de clientes en el ámbito académico, sanitario e industrial.
Oportunidad
- Crecientes avances en la tecnología NGS
La mayor velocidad, precisión, escalabilidad y rentabilidad de la secuenciación han ampliado significativamente las aplicaciones de la NGS en diversos campos, como la genómica , la oncología y las enfermedades infecciosas . Esta expansión de las aplicaciones no solo ha aumentado la demanda de tecnologías de NGS, sino que también ha abierto nuevos mercados. Además, la disminución del coste de la secuenciación ha hecho que la NGS sea más accesible para investigadores, médicos y pacientes, lo que ha impulsado aún más su adopción en el diagnóstico clínico y la medicina personalizada. Además, las innovaciones tecnológicas en curso, como el desarrollo de tecnologías de secuenciación de lectura larga y dispositivos de secuenciación portátiles, siguen recuperando el rendimiento y la facilidad de uso de las plataformas de NGS, mejorando su propuesta de valor para los clientes.
Restricción/Desafío
- Complejidad durante la implementación de NGS en el laboratorio clínico
La implementación de la secuenciación de nueva generación (NGS) en los laboratorios clínicos enfrenta varias limitaciones que pueden impedir el crecimiento del mercado de NGS. Una limitación importante es la complejidad y variabilidad de los datos de NGS. La enorme cantidad de datos genéticos generados requiere herramientas bioinformáticas sofisticadas para el análisis y la interpretación. Los laboratorios clínicos deben invertir en estos recursos y en personal capacitado para garantizar resultados precisos y procesables, lo que puede ser una barrera para la adopción. Otra limitación es la demanda de instrumentación avanzada y equipos especializados para NGS. Estos instrumentos pueden ser costosos y su mantenimiento requiere una inversión significativa en infraestructura y experiencia técnica. Los laboratorios clínicos más pequeños pueden tener dificultades para justificar el costo de estas inversiones, lo que limita la implementación generalizada de NGS.
Acontecimientos recientes
- En abril de 2024, Merck KGaA presentó el primer ensayo de estabilidad genética validado y todo en uno de la industria. El ensayo de estabilidad genética Aptegra CHO utiliza la secuenciación del genoma completo y la bioinformática para acelerar las pruebas de bioseguridad para los clientes, lo que facilita su transición a la producción comercial. Esta innovación ayudará a Merck KGaA a agilizar las pruebas de bioseguridad para los clientes, lo que permitirá transiciones más rápidas a la producción comercial y mejorará su competitividad en el mercado.
- En enero de 2024, QIAGEN ha actualizado su QIAGEN CLC Genomics Workbench Premium con tecnología LightSpeed para incluir compatibilidad con la secuenciación de próxima generación (NGS) en el análisis secundario del cáncer somático. Este acelerador de software convierte de manera eficiente los datos de secuenciación sin procesar de los archivos FASTQ en listas interpretables de variantes genéticas en archivos VCF a un costo notablemente bajo y a alta velocidad. Esta actualización fortalece la oferta de QIAGEN, brindando a los clientes una solución más rápida y rentable para el análisis NGS del cáncer somático, mejorando su competitividad.
- En enero de 2024, Beckman Coulter, Inc. se asoció con Polycarbin, una empresa pionera en soluciones de laboratorio sostenibles. Juntos, su objetivo es revolucionar la sostenibilidad de los laboratorios en el ámbito de los plásticos para la automatización del manejo de líquidos. Esta colaboración fusiona la experiencia de Beckman Coulter Life Sciences en el manejo automatizado de líquidos con la plataforma de economía circular de Polycarbin, que se centra en la sostenibilidad de los plásticos de laboratorio.
- En noviembre de 2023, QIAGEN y DNA Labs International colaboraron para resolver casos sin resolver de hace dos décadas utilizando el sistema ForenSeq Kintelligence de QIAGEN para la genealogía genética forense, junto con la base de datos GEDmatch PRO. Esto pone de relieve la eficacia y la creciente adopción de este enfoque para la identificación humana. Esto dará como resultado la eficacia de las soluciones de genealogía genética forense de QIAGEN, lo que podría impulsar su adopción y ventas en el mercado forense.
- En noviembre de 2023, Beckman Coulter, Inc. ha firmado un acuerdo de colaboración con Pillar Biosciences, un desarrollador y distribuidor de soluciones de pruebas NGS para IVD y RUO que utilizan su tecnología patentada SLIMamp. Como parte del acuerdo, Pillar Biosciences creará una serie de aplicaciones para su uso en el sistema de preparación de bibliotecas de próxima generación Biomek NGeniuS. Esta colaboración mejorará las ofertas de Beckman Coulter al integrar las soluciones avanzadas de pruebas NGS de Pillar Biosciences, lo que beneficiará a los pacientes con cáncer a través de una mejor selección de terapias de precisión.
- En noviembre de 2023, QIAGEN y Element Biosciences, Inc. anunciaron una asociación estratégica para proporcionar flujos de trabajo de secuenciación de próxima generación (NGS) integrales para el sistema Element AVITI, una innovadora plataforma de secuenciación. Esta asociación ampliará la cartera de flujos de trabajo de NGS de QIAGEN y fortalecerá su posición en el mercado de la genómica.
- En octubre de 2023, Beckman Coulter, Inc. y 10x Genomics se han asociado para mejorar las soluciones de automatización para los flujos de trabajo de ensayos de células individuales. En virtud de esta colaboración, 10x Genomics desarrollará kits de células individuales de cromo diseñados para su uso con el manipulador de líquidos automatizado Biomek i7 de Beckman Coulter Life Sciences. Esta aplicación personalizada tiene como objetivo automatizar la preparación de bibliotecas de células individuales de 10x Genomics, lo que garantiza una producción a gran escala y de alta calidad de bibliotecas terminadas listas para la secuenciación. Esta asociación permitirá a Beckman Coulter ofrecer soluciones de automatización mejoradas para ensayos de células individuales, lo que brindará a los clientes flujos de trabajo optimizados y una mayor eficiencia.
- En octubre de 2023, Azenta US, Inc. anunció que GENEWIZ Multiomics and Synthesis Solutions de Azenta Life Sciences organizará la Semana GENEWIZ del 6 al 10 de noviembre de 2023. El evento incluirá talleres virtuales, promociones y un programa de subvenciones para la excelencia en la investigación genómica. La celebración de la Semana GENEWIZ mejoró la visibilidad de la marca Azenta, atrajo nuevos clientes y fomentó colaboraciones en la comunidad de investigación genómica, impulsando en última instancia el crecimiento y la innovación.
- En septiembre de 2023, Charles River Laboratories y PathoQuest SAS, un proveedor de servicios de pruebas de secuenciación de próxima generación (NGS) para productos biofarmacéuticos, anunciaron que habían publicado conjuntamente una investigación pionera en Vaccine. Este estudio destacó las capacidades superiores de detección de contaminantes virales del ensayo basado en NGS patentado y de grado de buenas prácticas de fabricación (GMP) de PathoQuest en comparación con los ensayos in vivo. Este logro mejorará la reputación de la empresa y la posicionará como líder en pruebas biofarmacéuticas, atrayendo potencialmente a más clientes que buscan soluciones de pruebas avanzadas y confiables.
- En mayo de 2023, Charles River Laboratories presentó Accugenix Next Generation Sequencing for Bacterial Identification and Fungal Identification (Accugenix NGS). Esta tecnología secuencia millones de fragmentos de ADN individuales de una muestra, ofreciendo a los fabricantes de productos farmacéuticos y de cuidado personal información crucial sobre el control microbiano. La nueva tecnología mejora los servicios de la empresa, ofreciendo a los fabricantes de productos farmacéuticos y de cuidado personal soluciones avanzadas de control microbiano que mejoran la calidad del producto y el cumplimiento normativo.
Alcance del mercado global de secuenciación de próxima generación (NGS)
El mercado global de secuenciación de próxima generación (NGS) está segmentado en cinco segmentos notables según el producto y el servicio, la tecnología, la aplicación, el usuario final y el canal de distribución. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus áreas de aplicación principales y las diferencias en sus mercados objetivo.
Producto y servicio
- Consumibles
- Servicios
- Instrumentos
Sobre la base del producto y servicio, el mercado global de secuenciación de próxima generación (NGS) está segmentado en consumibles, servicios e instrumentos.
Tecnología
- Secuenciación por síntesis (SBS)
- Secuenciación por ligación (SBL)
- Otros
Sobre la base de la tecnología, el mercado global de secuenciación de próxima generación (NGS) está segmentado en secuenciación por síntesis (SBS), secuenciación por ligadura (SBL) y otros.
Solicitud
- Microbiología farmacéutica
- Descubrimiento de fármacos y biomarcadores
- Diagnóstico
- Medicina de precisión
- Investigación agrícola y animal
- Detección de patógenos en alimentos
- Otros
Sobre la base de la aplicación, el mercado global de secuenciación de próxima generación (NGS) está segmentado en microbiología farmacéutica, descubrimiento de fármacos y biomarcadores, diagnóstico, medicina de precisión, investigación agrícola y animal, detección de patógenos alimentarios y otros.
Usuario final
- Empresas farmacéuticas y biotecnológicas
- Institutos académicos y de investigación
- Hospitales y clínicas
- Laboratorios clínicos
- Organizaciones de investigación por contrato (CROS)
- Otros
Sobre la base del usuario final, el mercado global de secuenciación de próxima generación (NGS) está segmentado en empresas farmacéuticas y de biotecnología, institutos académicos y de investigación, hospitales y clínicas, laboratorios clínicos, organizaciones de investigación por contrato (CROS) y otros.
Canal de distribución
- Licitación directa
- Ventas al por menor
- Otros
Sobre la base del canal de distribución, el mercado global de secuenciación de próxima generación (NGS) está segmentado en licitación directa, ventas minoristas y otros.
Análisis y perspectivas regionales del mercado global de secuenciación de próxima generación (NGS)
Se analiza el mercado global de secuenciación de próxima generación (NGS) y se proporcionan información y tendencias del tamaño del mercado en función del producto y servicio, la tecnología, la aplicación, el usuario final y el canal de distribución como se mencionó anteriormente.
Los países cubiertos en este informe de mercado global de secuenciación de próxima generación (NGS) son EE. UU., Canadá y México, Reino Unido, Alemania, Francia, España, Italia, Bélgica, Rusia, Suiza, Países Bajos, Turquía, resto de Europa, China, Australia, Japón, India, Singapur, Corea del Sur, Malasia, Tailandia, Indonesia, Filipinas, resto de Asia-Pacífico, Brasil, Argentina y resto de Sudamérica, Sudáfrica, Egipto, Arabia Saudita, Emiratos Árabes Unidos, Israel y resto de Medio Oriente y África.
Se espera que América del Norte domine el mercado global de secuenciación de próxima generación (NGS) debido a factores como la presencia de una gran cantidad de actores clave del mercado, la alta adopción de tecnologías NGS en investigación y aplicaciones clínicas, e iniciativas gubernamentales favorables y financiación que apoyan la investigación genómica.
Se espera que Estados Unidos domine el mercado de secuenciación de próxima generación (NGS) de América del Norte debido a factores como la presencia de una gran cantidad de proveedores de tecnología NGS, inversiones significativas en investigación genómica y un entorno regulatorio favorable que promueve la adopción de NGS en entornos clínicos y de investigación.
Se espera que el Reino Unido domine el mercado europeo de secuenciación de próxima generación (NGS) debido a su avanzada infraestructura de atención médica, un fuerte apoyo gubernamental a la investigación genómica y un mercado bien establecido para tecnologías y servicios de NGS.
Se espera que China domine el mercado de secuenciación de próxima generación (NGS) de Asia y el Pacífico debido a su gran población, la creciente adopción de la medicina de precisión, las iniciativas gubernamentales para promover la investigación genómica y un número creciente de proveedores de tecnología NGS en la región.
La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación del mercado que afectan las tendencias actuales y futuras del mercado. Los puntos de datos como el análisis de la cadena de valor ascendente y descendente, las tendencias técnicas y el análisis de las cinco fuerzas de Porter, los estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.
Análisis del panorama competitivo y de la cuota de mercado global de la secuenciación de próxima generación (NGS)
El panorama competitivo del mercado global de secuenciación de próxima generación (NGS) proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en el mercado global de secuenciación de próxima generación (NGS).
Algunos de los principales actores que operan en el mercado global de secuenciación de próxima generación (NGS) son Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Charles River Laboratories, Revvity, Promega Corporation, Agilent Technologies, Inc., Takara Bio Inc., Eurofins Scientific, Hamilton Company, BGI, Azenta US, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., PacBio, Macrogen, Inc., Gilson Incorporated, New England Biolabs, Oxford Nanopore Technologies plc, LGC Biosearch Technologies, PCR Biosystems, ACT Genomics, Quantabio, DNASTAR y NimaGen, entre otros.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASE IN THE ADOPTION OF GENOME-FOCUSED PHARMACOLOGY
5.1.2 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS
5.1.3 USE OF NEXT GENERATION SEQUENCING IN DRUG DEVELOPMENT
5.1.4 INCREASE TREND TOWARDS PERSONALIZED MEDICATION
5.2 RESTRAINTS
5.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF EQUIPMENT’S IN THE LABORATORY
5.2.2 COMPLEXITY DURING IMPLEMENTATION OF NGS IN THE CLINICAL LAB
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS
5.3.2 INCREASING ADVANCEMENT IN NGS TECHNOLOGY
5.3.3 INCREASING APPLICATIONS OF NGS IN CLINICAL DIAGNOSTICS
5.4 CHALLENGES
5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM NGS
5.4.2 DATA PRIVACY AND SECURITY
6 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT AND SERVICE
6.1 OVERVIEW
6.2 CONSUMABLES
6.2.1 LIBRARY PREPARATION CONSUMABLES
6.2.2 SAMPLE PREPARATION CONSUMABLES
6.3 SERVICES
6.3.1 SEQUENCING SERVICES
6.3.1.1 RNA SEQUENCING
6.3.1.2 DNA SEQUENCING
6.3.1.2.1 WHOLE GENOME SEQUENCING
6.3.1.2.2 WHOLE EXOME SEQUENCING
6.3.1.2.3 TARGETED SEQUENCING
6.3.1.2.4 CHIP SEQUENCING
6.3.1.2.5 DE NOVO SEQUENCING
6.3.1.2.6 OTHERS
6.3.2 DATA MANAGEMENT SERVICES
6.3.2.1 NGS STORAGE, MANAGEMENT AND CLOUD COMPUTING SOLUTIONS
6.3.2.2 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES
6.3.2.3 NGS DATA ANALYSIS SERVICES
6.4 INSTRUMENTS
6.4.1 BENCHTOP
6.4.2 STANDALONE
6.4.2.1 AUTOMATED
6.4.2.2 SEMI-AUTOMATED
6.4.2.3 MANUAL
6.4.2.3.1 WORKSTATION/PLATFORM
6.4.2.3.2 SYSTEM
7 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 SEQUENCING BY SYNTHESIS (SBS)
7.2.1 PYROSEQUENCING
7.2.2 ION SEMI CONDUCTOR SEQUENCING
7.2.3 NANOPORE SEQUENCING
7.2.4 SINGLE-MOLECULE-REAL-TIME SEQUENCING (SMRT)
7.3 SEQUENCING BY LIGATION (SBL)
7.4 OTHERS
8 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 PHARMACEUTICALS MICROBIOLOGY
8.2.1 MICROBIAL IDENTIFICATION/DETECTION
8.2.2 TARGETED SEQUENCING
8.2.3 CELL LINE CHARACTERIZATION
8.2.4 ANTIMICROBIAL RESISTANCE AND PREDICTING ANTIMICROBIAL SUSCEPTIBILITIES
8.2.5 STRAIN SUBTYPING
8.2.6 OTHERS
8.2.6.1 SEQUENCING BY SYNTHESIS (SBS)
8.2.6.2 SEQUENCING BY LIGATION (SBL)
8.2.6.3 OTHERS
8.3 DRUG & BIOMARKER DISCOVERY
8.3.1 SEQUENCING BY SYNTHESIS (SBS)
8.3.2 SEQUENCING BY LIGATION (SBL)
8.3.3 OTHERS
8.4 DIAGNOSTICS
8.4.1 CANCER DIAGNOSTICS
8.4.2 INFECTIOUS DISEASE DIAGNOSTICS
8.4.3 REPRODUCTIVE HEALTH DIAGNOSTICS
8.4.4 OTHER DIAGNOSTIC APPLICATIONS
8.4.4.1 SEQUENCING BY SYNTHESIS (SBS)
8.4.4.2 SEQUENCING BY LIGATION (SBL)
8.4.5 OTHERS
8.5 PRECISION MEDICINE
8.5.1 SEQUENCING BY SYNTHESIS (SBS)
8.5.2 SEQUENCING BY LIGATION (SBL)
8.5.3 OTHERS
8.6 AGRICULTURAL & ANIMAL RESEARCH
8.6.1 SEQUENCING BY SYNTHESIS (SBS)
8.6.2 SEQUENCING BY LIGATION (SBL)
8.6.3 OTHERS
8.7 FOOD PATHOGEN SCREENING
8.8 OTHERS
9 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER
9.1 OVERVIEW
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 HOSPITALS & CLINICS
9.5 CLINICAL LABORATORIES
9.6 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.7 OTHERS
10 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDER
10.3 RETAIL SALES
10.3.1 OFFLINE
10.3.2 ONLINE
10.4 OTHERS
11 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 U.K.
11.3.2 GERMANY
11.3.3 FRANCE
11.3.4 SPAIN
11.3.5 ITALY
11.3.6 BELGIUM
11.3.7 RUSSIA
11.3.8 SWITZERLAND
11.3.9 NETHERLANDS
11.3.10 TURKEY
11.3.11 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 AUSTRALIA
11.4.3 JAPAN
11.4.4 INDIA
11.4.5 SINGAPORE
11.4.6 SOUTH KOREA
11.4.7 MALAYSIA
11.4.8 THAILAND
11.4.9 INDONESIA
11.4.10 PHILIPPINES
11.4.11 REST OF ASIA-PACIFIC
11.5 SOUTH AMERICA
11.5.1 BRAZIL
11.5.2 ARGENTINA
11.5.3 REST OF SOUTH AMERICA
11.6 MIDDLE EAST AND AFRICA
11.6.1 SOUTH AFRICA
11.6.2 SAUDI ARABIA
11.6.3 U.A.E.
11.6.4 ISRAEL
11.6.5 REST OF MIDDLE EAST AND AFRICA
12 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILING
14.1 ILLUMINA, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUEANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 THERMO FISHER SCIENTIFIC INC.
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 QIAGEN
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 MERCK KGAA
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 CHARLES RIVER LABORATORIES
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 ACT GENOMICS
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 AGILENT TECHNOLOGIES, INC.
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 AZENTA US, INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 BECKMAN COULTER, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 BIO-RAD LABORATORIES, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENTS
14.11 BGI (A SUBSIDIAIRY OF BGI GROUP) (2024)
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 DNASTAR
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 EUROFINS SCIENTIFIC
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENTS
14.14 GILSON INCORPORATED
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 HAMILTON COMPANY
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 LGC BIOSEARCH TECHNOLOGIES
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 MACROGEN, INC.
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENT
14.18 NEW ENGLAND BIOLABS
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
14.19 NIMAGEN
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 OXFORD NANOPORE TECHNOLOGIES PLC.
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENTS
14.21 PACBIO.
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
14.22 PCR BIOSYSTEMS
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENTS
14.23 PROMEGA CORPORATION.
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENTS
14.24 QUANTABIO
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 REVVITY
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENT
14.26 TAKARA BIO INC.
14.26.1 COMPANY SNAPSHOT
14.26.2 REVENUE ANALYSIS
14.26.3 PRODUCT PORTFOLIO
14.26.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
Lista de Tablas
TABLE 1 INSTRUMENT COST PER RUN
TABLE 2 PLATFORM /COMPANY COST PER RUN
TABLE 3 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 4 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 5 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 6 GLOBAL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 GLOBAL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 8 GLOBAL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 9 GLOBAL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 10 GLOBAL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 11 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 13 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 14 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 15 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 16 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 17 GLOBAL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 18 GLOBAL SEQUENCING BY LIGATION (SBL) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 19 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 21 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 24 GLOBAL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 25 GLOBAL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 26 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 28 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 29 GLOBAL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 30 GLOBAL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 31 GLOBAL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 32 GLOBAL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 33 GLOBAL FOOD PATHOGEN SCREENING IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 34 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 35 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 36 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 37 GLOBAL ACADEMIC & RESEARCH INSTITUTES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 38 GLOBAL HOSPITALS & CLINICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 39 GLOBAL CLINICAL LABORATORIES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 40 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 41 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 42 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 43 GLOBAL DIRECT TENDER IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 44 GLOBAL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 45 GLOBAL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 46 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 47 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 48 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 49 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 50 NORTH AMERICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 51 NORTH AMERICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 52 NORTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 53 NORTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 54 NORTH AMERICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 55 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 56 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 57 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 58 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 59 NORTH AMERICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 60 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 61 NORTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 62 NORTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 63 NORTH AMERICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 64 NORTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 65 NORTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 66 NORTH AMERICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 67 NORTH AMERICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 68 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 69 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 70 NORTH AMERICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 71 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 72 U.S. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 73 U.S. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 74 U.S. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 75 U.S. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 76 U.S. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 77 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 78 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 79 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 80 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 81 U.S. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 82 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 83 U.S. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 84 U.S. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 85 U.S. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 86 U.S. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 87 U.S. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 88 U.S. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 89 U.S. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 90 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 91 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 92 U.S. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 93 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 94 CANADA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 95 CANADA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 96 CANADA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 97 CANADA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 98 CANADA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 99 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 100 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 101 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 102 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 103 CANADA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 104 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 105 CANADA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 106 CANADA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 107 CANADA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 108 CANADA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 109 CANADA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 110 CANADA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 111 CANADA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 112 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 113 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 114 CANADA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 115 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 116 MEXICO CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 117 MEXICO SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 118 MEXICO SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 119 MEXICO SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 120 MEXICO DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 121 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 122 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 123 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 124 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 125 MEXICO SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 126 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 127 MEXICO PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 128 MEXICO PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 129 MEXICO DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 130 MEXICO DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 MEXICO DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 132 MEXICO PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 133 MEXICO AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 134 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 135 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 136 MEXICO RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 137 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 138 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 139 EUROPE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 140 EUROPE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 141 EUROPE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 142 EUROPE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 143 EUROPE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 144 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 145 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 146 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 147 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 148 EUROPE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 149 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 150 EUROPE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 151 EUROPE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 152 EUROPE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 153 EUROPE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 154 EUROPE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 155 EUROPE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 156 EUROPE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 157 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 158 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 159 EUROPE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 160 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 161 U.K. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 162 U.K. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 163 U.K. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 164 U.K. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 165 U.K. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 166 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 167 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 168 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 169 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 170 U.K. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 171 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 172 U.K. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 173 U.K. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 174 U.K. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 175 U.K. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 176 U.K. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 177 U.K. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 178 U.K. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 179 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 180 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 181 U.K. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 182 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 183 GERMANY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 184 GERMANY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 185 GERMANY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 186 GERMANY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 187 GERMANY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 188 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 189 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 190 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 191 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 192 GERMANY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 193 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 194 GERMANY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 195 GERMANY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 196 GERMANY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 197 GERMANY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 198 GERMANY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 199 GERMANY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 200 GERMANY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 201 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 202 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 203 GERMANY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 204 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 205 FRANCE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 206 FRANCE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 207 FRANCE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 208 FRANCE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 209 FRANCE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 210 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 211 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 212 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 213 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 214 FRANCE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 215 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 216 FRANCE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 217 FRANCE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 218 FRANCE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 219 FRANCE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 220 FRANCE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 221 FRANCE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 222 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 223 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 224 FRANCE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 225 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 226 SPAIN CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 227 SPAIN SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 228 SPAIN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 229 SPAIN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 230 SPAIN DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 231 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 232 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 233 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 234 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 235 SPAIN SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 236 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 237 SPAIN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 238 SPAIN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 239 SPAIN DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 240 SPAIN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 241 SPAIN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 242 SPAIN PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 243 SPAIN AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 244 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 245 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 246 SPAIN RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 247 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 248 ITALY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 249 ITALY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 250 ITALY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 251 ITALY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 252 ITALY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 253 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 254 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 255 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 256 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 257 ITALY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 258 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 259 ITALY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 260 ITALY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 261 ITALY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 262 ITALY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 263 ITALY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 264 ITALY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 265 ITALY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 266 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 267 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 268 ITALY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 269 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 270 BELGIUM CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 271 BELGIUM SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 272 BELGIUM SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 273 BELGIUM SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 274 BELGIUM DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 275 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 276 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 277 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 278 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 279 BELGIUM SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 280 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 281 BELGIUM PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 282 BELGIUM PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 283 BELGIUM DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 284 BELGIUM DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 285 BELGIUM DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 286 BELGIUM PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 287 BELGIUM AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 288 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 289 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 290 BELGIUM RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 291 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 292 RUSSIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 293 RUSSIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 294 RUSSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 295 RUSSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 296 RUSSIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 297 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 298 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 299 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 300 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 301 RUSSIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 302 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 303 RUSSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 304 RUSSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 305 RUSSIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 306 RUSSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 307 RUSSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 308 RUSSIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 309 RUSSIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 310 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 311 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 312 RUSSIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 313 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 314 SWITZERLAND CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 315 SWITZERLAND SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 316 SWITZERLAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 317 SWITZERLAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 318 SWITZERLAND DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 319 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 320 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 321 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 322 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 323 SWITZERLAND SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 324 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 325 SWITZERLAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 326 SWITZERLAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 327 SWITZERLAND DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 328 SWITZERLAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 329 SWITZERLAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 330 SWITZERLAND PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 331 SWITZERLAND AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 332 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 333 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 334 SWITZERLAND RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 335 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 336 NETHERLANDS CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 337 NETHERLANDS SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 338 NETHERLANDS SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 339 NETHERLANDS SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 340 NETHERLANDS DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 341 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 342 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 343 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 344 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 345 NETHERLANDS SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 346 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 347 NETHERLANDS PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 348 NETHERLANDS PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 349 NETHERLANDS DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 350 NETHERLANDS DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 351 NETHERLANDS DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 352 NETHERLANDS PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 353 NETHERLANDS AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 354 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 355 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 356 NETHERLANDS RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 357 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 358 TURKEY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 359 TURKEY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 360 TURKEY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 361 TURKEY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 362 TURKEY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 363 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 364 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 365 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 366 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 367 TURKEY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 368 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 369 TURKEY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 370 TURKEY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 371 TURKEY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 372 TURKEY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 373 TURKEY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 374 TURKEY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 375 TURKEY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 376 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 377 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 378 TURKEY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 379 REST OF EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 380 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 381 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 382 ASIA-PACIFIC CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 383 ASIA-PACIFIC SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 384 ASIA-PACIFIC SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 385 ASIA-PACIFIC SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 386 ASIA-PACIFIC DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 387 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 388 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 389 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 390 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 391 ASIA-PACIFIC SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 392 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 393 ASIA-PACIFIC PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 394 ASIA-PACIFIC PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 395 ASIA-PACIFIC DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 396 ASIA-PACIFIC DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 397 ASIA-PACIFIC DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 398 ASIA-PACIFIC PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 399 ASIA-PACIFIC AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 400 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 401 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 402 ASIA-PACIFIC RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 403 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 404 CHINA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 405 CHINA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 406 CHINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 407 CHINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 408 CHINA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 409 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 410 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 411 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 412 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 413 CHINA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 414 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 415 CHINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 416 CHINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 417 CHINA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 418 CHINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 419 CHINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 420 CHINA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 421 CHINA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 422 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 423 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 424 CHINA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 425 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 426 AUSTRALIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 427 AUSTRALIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 428 AUSTRALIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 429 AUSTRALIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 430 AUSTRALIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 431 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 432 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 433 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 434 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 435 AUSTRALIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 436 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 437 AUSTRALIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 438 AUSTRALIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 439 AUSTRALIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 440 AUSTRALIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 441 AUSTRALIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 442 AUSTRALIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 443 AUSTRALIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 444 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 445 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 446 AUSTRALIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 447 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 448 JAPAN CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 449 JAPAN SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 450 JAPAN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 451 JAPAN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 452 JAPAN DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 453 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 454 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 455 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 456 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 457 JAPAN SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 458 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 459 JAPAN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 460 JAPAN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 461 JAPAN DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 462 JAPAN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 463 JAPAN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 464 JAPAN PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 465 JAPAN AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 466 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 467 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 468 JAPAN RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 469 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 470 INDIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 471 INDIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 472 INDIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 473 INDIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 474 INDIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 475 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 476 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 477 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 478 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 479 INDIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 480 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 481 INDIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 482 INDIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 483 INDIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 484 INDIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 485 INDIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 486 INDIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 487 INDIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 488 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 489 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 490 INDIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 491 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 492 SINGAPORE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 493 SINGAPORE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 494 SINGAPORE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 495 SINGAPORE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 496 SINGAPORE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 497 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 498 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 499 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 500 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 501 SINGAPORE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 502 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 503 SINGAPORE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 504 SINGAPORE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 505 SINGAPORE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 506 SINGAPORE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 507 SINGAPORE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 508 SINGAPORE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 509 SINGAPORE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 510 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 511 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 512 SINGAPORE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 513 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 514 SOUTH KOREA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 515 SOUTH KOREA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 516 SOUTH KOREA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 517 SOUTH KOREA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 518 SOUTH KOREA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 519 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 520 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 521 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 522 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 523 SOUTH KOREA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 524 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 525 SOUTH KOREA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 526 SOUTH KOREA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 527 SOUTH KOREA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 528 SOUTH KOREA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 529 SOUTH KOREA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 530 SOUTH KOREA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 531 SOUTH KOREA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 532 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 533 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 534 SOUTH KOREA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 535 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 536 MALAYSIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 537 MALAYSIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 538 MALAYSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 539 MALAYSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 540 MALAYSIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 541 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 542 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 543 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 544 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 545 MALAYSIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 546 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 547 MALAYSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 548 MALAYSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 549 MALAYSIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 550 MALAYSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 551 MALAYSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 552 MALAYSIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 553 MALAYSIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 554 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 555 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 556 MALAYSIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 557 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 558 THAILAND CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 559 THAILAND SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 560 THAILAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 561 THAILAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 562 THAILAND DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 563 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 564 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 565 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 566 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 567 THAILAND SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 568 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 569 THAILAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 570 THAILAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 571 THAILAND DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 572 THAILAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 573 THAILAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 574 THAILAND PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 575 THAILAND AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 576 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 577 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 578 THAILAND RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 579 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 580 INDONESIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 581 INDONESIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 582 INDONESIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 583 INDONESIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 584 INDONESIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 585 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 586 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 587 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 588 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 589 INDONESIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 590 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 591 INDONESIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 592 INDONESIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 593 INDONESIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 594 INDONESIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 595 INDONESIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 596 INDONESIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 597 INDONESIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 598 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 599 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 600 INDONESIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 601 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 602 PHILIPPINES CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 603 PHILIPPINES SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 604 PHILIPPINES SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 605 PHILIPPINES SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 606 PHILIPPINES DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 607 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 608 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 609 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 610 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 611 PHILIPPINES SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 612 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 613 PHILIPPINES PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 614 PHILIPPINES PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 615 PHILIPPINES DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 616 PHILIPPINES DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 617 PHILIPPINES DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 618 PHILIPPINES PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 619 PHILIPPINES AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 620 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 621 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 622 PHILIPPINES RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 623 REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 624 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 625 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 626 SOUTH AMERICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 627 SOUTH AMERICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 628 SOUTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 629 SOUTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 630 SOUTH AMERICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 631 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 632 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 633 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 634 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 635 SOUTH AMERICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 636 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 637 SOUTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 638 SOUTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 639 SOUTH AMERICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 640 SOUTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 641 SOUTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 642 SOUTH AMERICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 643 SOUTH AMERICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 644 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 645 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 646 SOUTH AMERICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 647 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 648 BRAZIL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 649 BRAZIL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 650 BRAZIL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 651 BRAZIL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 652 BRAZIL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 653 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 654 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 655 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 656 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 657 BRAZIL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 658 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 659 BRAZIL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 660 BRAZIL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 661 BRAZIL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 662 BRAZIL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 663 BRAZIL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 664 BRAZIL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 665 BRAZIL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 666 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 667 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 668 BRAZIL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 669 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 670 ARGENTINA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 671 ARGENTINA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 672 ARGENTINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 673 ARGENTINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 674 ARGENTINA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 675 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 676 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 677 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 678 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 679 ARGENTINA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 680 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 681 ARGENTINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 682 ARGENTINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 683 ARGENTINA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 684 ARGENTINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 685 ARGENTINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 686 ARGENTINA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 687 ARGENTINA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 688 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 689 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 690 ARGENTINA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 691 REST OF SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 692 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 693 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 694 MIDDLE EAST & AFRICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 695 MIDDLE EAST & AFRICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 696 MIDDLE EAST & AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 697 MIDDLE EAST & AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 698 MIDDLE EAST & AFRICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 699 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 700 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 701 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 702 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 703 MIDDLE EAST & AFRICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 704 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 705 MIDDLE EAST & AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 706 MIDDLE EAST & AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 707 MIDDLE EAST & AFRICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 708 MIDDLE EAST & AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 709 MIDDLE EAST & AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 710 MIDDLE EAST & AFRICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 711 MIDDLE EAST & AFRICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 712 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 713 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 714 MIDDLE EAST & AFRICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 715 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 716 SOUTH AFRICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 717 SOUTH AFRICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 718 SOUTH AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 719 SOUTH AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 720 SOUTH AFRICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 721 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 722 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 723 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 724 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 725 SOUTH AFRICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 726 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 727 SOUTH AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 728 SOUTH AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 729 SOUTH AFRICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 730 SOUTH AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 731 SOUTH AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 732 SOUTH AFRICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 733 SOUTH AFRICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 734 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 735 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 736 SOUTH AFRICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 737 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 738 SAUDI ARABIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 739 SAUDI ARABIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 740 SAUDI ARABIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 741 SAUDI ARABIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 742 SAUDI ARABIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 743 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 744 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 745 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 746 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 747 SAUDI ARABIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 748 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 749 SAUDI ARABIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 750 SAUDI ARABIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 751 SAUDI ARABIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 752 SAUDI ARABIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 753 SAUDI ARABIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 754 SAUDI ARABIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 755 SAUDI ARABIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 756 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 757 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 758 SAUDI ARABIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 759 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 760 U.A.E. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 761 U.A.E. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 762 U.A.E. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 763 U.A.E. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 764 U.A.E. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 765 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 766 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 767 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 768 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 769 U.A.E. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 770 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 771 U.A.E. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 772 U.A.E. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 773 U.A.E. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 774 U.A.E. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 775 U.A.E. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 776 U.A.E. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 777 U.A.E. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 778 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 779 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 780 U.A.E. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 781 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 782 EGYPT CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 783 EGYPT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 784 EGYPT SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 785 EGYPT SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 786 EGYPT DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 787 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 788 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 789 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 790 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 791 EGYPT SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 792 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 793 EGYPT PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 794 EGYPT PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 795 EGYPT DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 796 EGYPT DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 797 EGYPT DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 798 EGYPT PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 799 EGYPT AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 800 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 801 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 802 EGYPT RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 803 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 804 ISRAEL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 805 ISRAEL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 806 ISRAEL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 807 ISRAEL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 808 ISRAEL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 809 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 810 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 811 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 812 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 813 ISRAEL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 814 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 815 ISRAEL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 816 ISRAEL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 817 ISRAEL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 818 ISRAEL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 819 ISRAEL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 820 ISRAEL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 821 ISRAEL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 822 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 823 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 824 ISRAEL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 825 REST OF MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
Lista de figuras
FIGURE 1 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SEGMENTATION
FIGURE 2 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SEGMENTATION
FIGURE 11 INCREASING ADOPTION OF NGS-BASED TESTS IN ONCOLOGY, PRENATAL SCREENING, AND INFECTIOUS DISEASE SURVEILLANCE IS DRIVING THE GROWTH OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET FROM 2024 TO 2031
FIGURE 12 THE PRODUCT AND SERVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET IN 2024 AND 2031
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR NEXT GENERATION SEQUENCING (NGS) MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET
FIGURE 16 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICE 2023
FIGURE 17 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICES, 2024-2031 (USD MILLION)
FIGURE 18 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICE, CAGR (2024-2031)
FIGURE 19 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET BY PRODUCT AND SERVICE, LIFELINE CURVE
FIGURE 20 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOGY 2023
FIGURE 21 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOG, 2024-2031 (USD MILLION)
FIGURE 22 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOG, CAGR (2024-2031)
FIGURE 23 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET BY TECHNOLOG, LIFELINE CURVE
FIGURE 24 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, 2023
FIGURE 25 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 26 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, CAGR (2024-2031)
FIGURE 27 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, LIFELINE CURVE
FIGURE 28 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, 2023
FIGURE 29 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, 2024-2031 (USD MILLION)
FIGURE 30 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, CAGR (2024-2031)
FIGURE 31 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, LIFELINE CURVE
FIGURE 32 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, 2023
FIGURE 33 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 34 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 35 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 36 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SNAPSHOT (2023)
FIGURE 37 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
FIGURE 38 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
FIGURE 39 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
FIGURE 40 AISA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
